India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border 
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links 
New York Legalizes Medical Aid in Dying for Terminally Ill Patients 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Federal Judge Restores Funding for Gateway Rail Tunnel Project 
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages 
U.S. President Donald Trump asked the help of American pharmaceutical firms that are currently working on experimental COVID-19 treatments to offer their drugs to Boris Johnson. The British Prime Minister has been moved to the I.C.U. after his coronavirus symptoms worsened.
“I’ve asked two of the leading companies,” Donald Trump said during a press conference, The Guardian reported. “They’ve come with the solutions and just have done incredible jobs – and I’ve asked him to contact London immediately.”
Trump said that the drugs are already in London and ready for use. “They’ve really advanced therapeutics … and they have arrived in London already,” the U.S. President said. “The London office has whatever they need. We’ll see if we can be of help. We’ve contacted all of Boris’s doctors, and we’ll see what is going to take place, but they are ready to go.”
The President did not specifically mention the name of the drugs or the pharmaceutical companies that made them. However, The Guardian noted that Trump had an earlier conference with the heads of biotech and pharmaceutical firms Amgen, Genetech, Gilead and Regeneron, pointed out that
However, Trump revealed that it’s still not certain if Boris Johnson would opt for the experimental treatments. “They’ve had meetings with the doctors, and we’ll see whether or not they want to go that route,” he said. “But when you’re in intensive care it’s a big deal. So they’re there and they’re ready.”
Donald Trump expressed sadness over what happened to his British counterpart, whom he considers to be one of his closest allies. “We’re very saddened to hear that he was taken into intensive care this afternoon, a little while ago, and Americans are all praying for his recovery,” Trump said. “He’s been a really good friend. He’s been really something very special: strong, resolute, doesn’t quit, doesn’t give up.”
Johnson has been moved to intensive care on Monday afternoon after his symptoms worsened, according to BBC. “Over the course of [Monday] afternoon, the condition of the prime minister has worsened and, on the advice of his medical team, he has been moved to the intensive care unit at the hospital,” a statement from No. 10 Downing Street reads.
